Published • loading... • Updated
InterContinental Beverage Capital Partners with PanTheryx to Accelerate Growth of GLP-1 Support Brand Relesium (R)
Summary by digitalmarketreports.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
InterContinental Beverage Capital Partners with PanTheryx to Accelerate Growth of GLP-1 Support Brand Relesium (R)
InterContinental Beverage Capital (IBC), a global advisory firm specializing in the beverage and consumer packaged goods industries, today announced a partnership with nutrition and biotechnology company PanTheryx to lead the commercial expansion of Relesium®. Relesium is a patented, all-natural supplement designed to address digestive side effects associated with GLP-1 medications. Under the partnership, IBC will collaborate with PanTheryx lead…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
